1. Home
  2. CTNM vs HURC Comparison

CTNM vs HURC Comparison

Compare CTNM & HURC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTNM
  • HURC
  • Stock Information
  • Founded
  • CTNM 2009
  • HURC 1968
  • Country
  • CTNM United States
  • HURC United States
  • Employees
  • CTNM N/A
  • HURC N/A
  • Industry
  • CTNM
  • HURC Industrial Machinery/Components
  • Sector
  • CTNM
  • HURC Industrials
  • Exchange
  • CTNM Nasdaq
  • HURC Nasdaq
  • Market Cap
  • CTNM 122.9M
  • HURC 104.0M
  • IPO Year
  • CTNM 2024
  • HURC N/A
  • Fundamental
  • Price
  • CTNM $3.85
  • HURC $19.60
  • Analyst Decision
  • CTNM Strong Buy
  • HURC
  • Analyst Count
  • CTNM 4
  • HURC 0
  • Target Price
  • CTNM $22.50
  • HURC N/A
  • AVG Volume (30 Days)
  • CTNM 222.5K
  • HURC 42.0K
  • Earning Date
  • CTNM 08-12-2025
  • HURC 06-06-2025
  • Dividend Yield
  • CTNM N/A
  • HURC N/A
  • EPS Growth
  • CTNM N/A
  • HURC N/A
  • EPS
  • CTNM N/A
  • HURC N/A
  • Revenue
  • CTNM N/A
  • HURC $183,634,000.00
  • Revenue This Year
  • CTNM N/A
  • HURC N/A
  • Revenue Next Year
  • CTNM N/A
  • HURC N/A
  • P/E Ratio
  • CTNM N/A
  • HURC N/A
  • Revenue Growth
  • CTNM N/A
  • HURC N/A
  • 52 Week Low
  • CTNM $3.35
  • HURC $13.19
  • 52 Week High
  • CTNM $22.00
  • HURC $23.76
  • Technical
  • Relative Strength Index (RSI)
  • CTNM N/A
  • HURC 79.39
  • Support Level
  • CTNM N/A
  • HURC $15.33
  • Resistance Level
  • CTNM N/A
  • HURC $19.80
  • Average True Range (ATR)
  • CTNM 0.00
  • HURC 0.94
  • MACD
  • CTNM 0.00
  • HURC 0.52
  • Stochastic Oscillator
  • CTNM 0.00
  • HURC 96.43

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

About HURC Hurco Companies Inc.

Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metalworking industry through sales, service, and distribution networks. The company concentrated on designing user-friendly computer control systems that both skilled and unskilled machine tool operators can operate. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of its revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.

Share on Social Networks: